Moreover, we previously administered 80 mg of PC-SOD repeatedly for 7 days in a phase I study conducted in healthy volunteers, and safely repeated the dosing over 14 days in a phase II study performed in patients with ulcerative colitis who did not show acute lung injury[11]. The gene discussed is SOD1; the disease is ulcerative colitis.